{
    "2019-06-24": [
        [
            {
                "time": "",
                "original_text": "创新药崛起时代，CRO是否迎来机会？",
                "features": {
                    "keywords": [
                        "创新药",
                        "CRO",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "普莱柯(603566.SH)拟与泰格医药投资平台、观由投资等设立投资基金 重点投资CRO领域",
                "features": {
                    "keywords": [
                        "普莱柯",
                        "泰格医药",
                        "投资基金",
                        "CRO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药研发变革大潮下，方达控股（1521.HK）借力资本加速度",
                "features": {
                    "keywords": [
                        "医药研发",
                        "方达控股",
                        "资本",
                        "加速度"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:医药政策进入密集落地期,聚焦科创板、医药创新和医药消费",
                "features": {
                    "keywords": [
                        "医药政策",
                        "科创板",
                        "医药创新",
                        "医药消费"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}